Attached files
| file | filename |
|---|---|
| 10-K - COPYTELE, INC. 10-K - Anixa Biosciences Inc | a6160172.htm |
| EX-4.1 - EXHIBIT 4.1 - Anixa Biosciences Inc | a6160172ex4-1.htm |
| EX-4.2 - EXHIBIT 4.2 - Anixa Biosciences Inc | a6160172ex4-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Anixa Biosciences Inc | a6160172ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Anixa Biosciences Inc | a6160172ex31-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Anixa Biosciences Inc | a6160172ex32-1.htm |
| EX-32.2 - EXHIBIT 32.2 - Anixa Biosciences Inc | a6160172ex32-2.htm |
| EX-23.2 - EXHIBIT 23.2 - Anixa Biosciences Inc | a6160172ex23-2.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting
Firm
The Board of Directors
CopyTele, Inc.:
We consent to the incorporation by reference in the
registration statement (Nos. 333-72716, 333-62381, 333-16933, 333-53416,
333-69650, 333-99717, 333-105012, 333-120333, 333-132544, 333-146261 and
333-156836) on Form S-8 of CopyTele, Inc. of our report dated January 29, 2010,
with respect to the consolidated balance sheet of CopyTele, Inc. and
subsidiaries as of October 31, 2009, and the related consolidated
statements of operations, shareholders’ equity and cash flows for the year then
ended, and the related financial statement schedule included in Item 15 (a) (1)
(2), which report appears in the October 31, 2009 annual report on Form
10-K of CopyTele, Inc..
KPMG LLP
Melville, New York
January 29, 2010